leish-111f + mpl-se
Vaccineexperimental
Clinical trial activity
5 trials · 7 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2004 (NCT00111514)
Timeline
Indications
Mechanism of action
- Leishmania sp.Immunity, active
Leishmania sp. immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- leish-111f + mpl-se
- leish-111f + mpl-se v
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00486382 | Phase 1 | Apr 1, 2007 | Banaras Hindu University, Bill and Melinda Gates Foundation, Immune Design, Infectious Disease Research Institute |
| NCT00121849 | Phase 1 | Aug 1, 2005 | Bill and Melinda Gates Foundation, Infectious Disease Research Institute, PECET, Medellin, Colombia |
| NCT00121862 | Phase 2 | Aug 1, 2005 | Bill and Melinda Gates Foundation, Immune Design, Infectious Disease Research Institute |
| NCT00111553 | Phase 1 | Oct 1, 2004 | Bill and Melinda Gates Foundation, Federal University of Minas Gerais, Infectious Disease Research Institute |
| NCT00111514 | Phase 1 | Jul 1, 2004 | Bill and Melinda Gates Foundation, Cayetano Heredia University, Immune Design, Infectious Disease Research Institute |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (7)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Bill and Melinda Gates Foundation | Academic/Hospital | 5 | 0 | 2 | 2004 |
| Infectious Disease Research Institute | Academic/Hospital | 5 | 5 | 2 | 2004 |
| Immune Design | For profit | 3 | 0 | 2 | 2004 |
| Banaras Hindu University | Academic/Hospital | 1 | 0 | 1 | 2007 |
| Cayetano Heredia University | Academic/Hospital | 1 | 0 | 1 | 2004 |
| Federal University of Minas Gerais | Academic/Hospital | 1 | 0 | 1 | 2004 |
| PECET, Medellin, Colombia | Academic/Hospital | 1 | 0 | 1 | 2005 |
7 organizations
Page 1 / 1